Indiana Medicaid (IHCP)Medicaid · Coverage · Medical Policy · IN · Pulmonology, Infectious Disease, PediatricsMedium impact
BT202597: Coverage added for inhaled agent for cystic fibrosis Pulmozyme (J7639) under the IHCP medical benefit
Act
by Aug 1, 2025
Effective date
Aug 1, 2025
Identified
Jun 18, 2026
Summary
Indiana Health Coverage Programs (IHCP) is adding coverage for Pulmozyme (dornase alfa) under the medical benefit effective August 1, 2025, using HCPCS code J7639. This inhaled medication for cystic fibrosis will require prior authorization with the same criteria as the existing pharmacy benefit, including age 5+ and prescription by a specialist.
Get alerts when payers change rules like this one
We check Indiana Medicaid (IHCP) and other payers every day and email you when a change matches your specialty and state.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.